Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostatic Cancer Recurrent”

819 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 819 results

Testing effectiveness (Phase 2)Ended earlyNCT00103376
What this trial is testing

Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 23
Testing effectiveness (Phase 2)Study completedNCT00589420
What this trial is testing

Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 18
Not applicableStudy completedNCT00176579
What this trial is testing

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

Who this might be right for
OsteoporosisProstate Cancer
University of Medicine and Dentistry of New Jersey 27
Not applicableLooking for participantsNCT07184970
What this trial is testing

PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound

Who this might be right for
Prostate Cancer
NYU Langone Health 60
Testing effectiveness (Phase 2)Ended earlyNCT00176631
What this trial is testing

Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 10
Not applicableLooking for participantsNCT06859203
What this trial is testing

A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PET

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Technical University of Munich 94
Testing effectiveness (Phase 2)Study completedNCT02488070
What this trial is testing

68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate Carcinoma
Stanford University 10
Early research (Phase 1)Study completedNCT00004929
What this trial is testing

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableUnknownNCT03507595
What this trial is testing

Evaluation of the Metastasis and Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer MetastaticProstate Cancer Recurrent+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 400
Testing effectiveness (Phase 2)Study completedNCT03515577
What this trial is testing

Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery

Who this might be right for
Recurrent Prostate Carcinoma
Jonsson Comprehensive Cancer Center 50
Large-scale testing (Phase 3)Looking for participantsNCT06650579
What this trial is testing

REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial

Who this might be right for
Recurrent Prostate CarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8
Emory University 72
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00005627
What this trial is testing

Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00309894
What this trial is testing

Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy

Who this might be right for
Prostate Cancer
University of California, San Francisco 49
Testing effectiveness (Phase 2)Study completedNCT00776594
What this trial is testing

Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 102
Testing effectiveness (Phase 2)Study completedNCT01051570
What this trial is testing

Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 26
Testing effectiveness (Phase 2)Study completedNCT00170157
What this trial is testing

Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaProstate CarcinomaRecurrent Prostate Carcinoma+2 more
Mayo Clinic 112
Large-scale testing (Phase 3)Ended earlyNCT00005075
What this trial is testing

Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
EDAP Technomed
Early research (Phase 1)Study completedNCT00313599
What this trial is testing

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more
University of California, San Francisco 28
Load More Results